10X Genomics Inc vs VNET Group Inc — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: 10X Genomics Inc is far larger — about 2.5× VNET Group Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.
| TXG | VNET | |
|---|---|---|
Market Cap | $5.48B | $2.19B |
Sector | Health | Technology |
52-Week High | $45.80 | $14.03 |
52-Week Low | $11.34 | $7.34 |
Enterprise Value | $5.02B | $5.32B |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →